TOP
|
特許
|
意匠
|
商標
商標ウォッチ
Twitter
他の商標を見る
公開日
2024-07-24
公報種別
公開国際商標公報
国際登録番号
1790851
国際登録日
2024-01-23
区分
第5類(薬剤)
,
第41類(教育・娯楽)
,
第44類(医療・農林業)
商品役務
Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders
,
muscular dystrophies
,
central nervous system diseases and disorders
,
genetic diseases and disorders; Pharmaceutical preparations based on morpholino oligomer technology platform for the treatment of neuromuscular diseases and disorders
,
muscular dystrophies
,
central nervous system diseases and disorders
,
genetic diseases and disorders
,
and for the regulation of protein production; Pharmaceutical preparations that modulate RNA expression for the treatment of neuromuscular diseases and disorders
,
muscular dystrophies
,
central nervous system diseases and disorders
,
genetic diseases and disorders
,
and for the regulation of protein production; Gene therapy products
,
namely
,
gene delivery pharmaceuticals; Pharmaceutical preparations for gene therapy
,
gene editing
,
and genome editing; Gene therapy products in the nature of pharmaceuticals for the treatment of neuromuscular diseases and disorders
,
muscular dystrophies
,
central nervous system diseases and disorders
全 29 件を表示
,
genetic diseases and disorders; Biological preparations for the treatment of neuromuscular diseases and disorders
,
muscular dystrophies
,
central nervous system diseases and disorders
,
genetic diseases and disorders; Viruses
,
viral vectors and viral constructs for the treatment of neuromuscular diseases and disorders
,
muscular dystrophies
,
central nervous system diseases and disorders
,
genetic diseases and disorders; Pharmaceutical preparations
,
biological preparations and gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of genetic disorders and diseases.
,
Medical training and teaching.
,
Medical services; providing health information.
基礎出願番号
98370905
基礎出願日
2024-01-23
基礎出願国
US
出願人
Sarepta Therapeutics, Inc.
OCRテキスト
(う MYOPEPDYS (vesleteplirsen) injection
OCRテキスト2
MYOPEPDYS (vesleteplirsen)injection
OCRについて
この商標をJ-PlatPatで参照する
関連商標
Huang, Ke
9日前
Aston Group Worldwide Ltd
INESSA
1か月前
Biohaven Therapeutics Ltd.
REJUTRIA
1か月前
Huang, Ke
9日前
MAFRA GROUP S.r.l.
MANIAC LINE
1か月前
F. Hoffmann-La Roche AG
IMRASGO
12日前
Developing Countries Vaccine Manufactures Network
12日前
Developing Countries Vaccine Manufactures Network
DCVMN INTERNATIONAL DevelopingCountriesVaccine ManufacturersNetworkInternational WECONNECTTOPROTECT!
12日前
F. Hoffmann-La Roche AG
SUNFENVO
12日前
F. Hoffmann-La Roche AG
STUVEYAH
12日前
Telix Pharmaceuticals Limited
PROLUMINAR
12日前
FAMILLE MICHAUD APICULTEURS
BEELIZ
12日前
F. Hoffmann-La Roche AG
VYVHALI
12日前
F. Hoffmann-La Roche AG
REHALYNZ
12日前
F. Hoffmann-La Roche AG
LIFSTUVA
12日前
Vir Biotechnology, Inc.
VirBiotechnology
12日前
Vir Biotechnology, Inc.
12日前
Developing Countries Vaccine Manufactures Network
Developing Countries Vaccine 8 InternationalManufacturers
12日前
MR. KARAN AGRAWAL, MR. LALIT AGRAWAL, MR.GHANSHYAM KUMAR ALL ARE PARTNERS OF Om Shiva Products Inc.
VITO
12日前
F. Hoffmann-La Roche AG
REMRASGY
12日前
European Foundation for the care of newborn infants (EFCNI)
9日前
Soho Flordis International Pty Ltd
9日前
Natmedics GmbH
9日前
HansolBio
9日前
Lycored Ltd.
9日前
BEIJING INNO MEDICINE CO., LTD.
9日前
Shanghai Qianzhi Care Products Co., Ltd.
9日前
Dong-A Pharmaceutical Co., Ltd.
9日前
Biohaven Therapeutics Ltd.
1か月前
OCuSOFT INC.
OUST
12日前
F. Hoffmann-La Roche AG
IKRASKO
12日前
Stratpharma AG
COLSIGEN
12日前
NODCURE INC.
nBiome
12日前
CENTARIX BIOTECH LTD.
Centa
12日前
METAVIA INC.
METAVIA
12日前
Shenzhen Wandao Cell Technology Co., Ltd.
WonderCel THERAPEUTICS
12日前
続きを見る
他の商標を見る